US 6995261
4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors
expired A61PA61P19/02A61P29/00
Quick answer
US patent 6995261 (4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P19/02, A61P29/00, A61P35/00, A61P43/00